Lactocore

Lactocore Group is a private, preclinical-stage biotech firm based in Munich, Germany, founded in 2015. It is advancing a pipeline of peptide drugs targeting significant unmet needs in neurology and metabolism, utilizing a specialized discovery and optimization platform. The company operates as a pre-revenue entity, likely funded by venture capital and grants, positioning itself in the competitive but high-potential neuropeptide therapeutics space. Its success hinges on translating its platform technology into clinically validated candidates and securing strategic partnerships for development.

Proprietary peptide discovery and optimization platform for designing therapeutics targeting specific receptors and pathways.

Lactocore competes in the peptide therapeutics space with companies like Amgen, Novo Nordisk (in metabolism), and numerous biotechs (e.g., Zealand Pharma, Bicycle Therapeutics). Differentiation requires demonstrating superior drug properties, novel targets, or efficacy in hard-to-treat disorders.